Jay B. Hunt
Banking Relationships, Turnarounds
& Family Business Matters

Jay is an expert at identifying core competencies and marketing leverage to reposition a company and its products and services. He is also an expert at working with businesses and families in crisis. He has successfully helped many closely held businesses work through issues ranging from intergenerational conflict to operating conflicts arising from the underperformance of family owned assets.

Jay has over 30 years of corporate governance and management experience including service as Non-Executive Chair of DDi Corp., Inc. (NASDAQ:DDIC, www.ddiglobal.com) since 2003 and a member of its Audit and Compensation Committees. DDi is a leading provider of time-critical, technologically advanced electronics manufacturing services for the electronics industry. Under his leadership, DDi has completely realigned its management team, refinanced its balance sheet, sharpened its strategic focus, disposed of unproductive operating assets and done an accretive acquisition. Since 1994, he has also been a Member of the Advisory Board for Joie de Vivre Hospitality (JDV). JDV (www.jdvhospitality.com) owns and/or manages 40 businesses including hotels, spas and restaurants and has revenues of $250 million. The Advisory Board has been involved in advising the CEO and Founder on every important decision during that time. These have included: capital and organizational structure and focus to responding to the events of September 11 and the telecom implosion in 2001-2002 to the most recent economic crisis as well as the development of a strategic plan that has moved the company to a dominant position in its market. He was also a Director of Gentiae Clinical Research, Inc., a venture capital backed global specialty clinical research organization for cardiac safety monitoring, imaging and cardiovascular clinical research in drug and device development.

Jay was also a Director of Electronic Medical Management, Inc. (EMMI). EMMI, prior to his involvement, had entered into a reverse merger with a public shell company which was found to be tainted resulting in an SEC enforcement action requiring the establishment of a rescission fund for shareholders. Under Jay’s guidance, the company retained counsel and went private. Jay was a Director Nominee on a slate for F. Hoffman-La Roche (Roche Pharmaceuticals) in connection with Roche’s hostile tender offer for Ventana Medical Systems, Inc. (VMA). Roche commenced an unsolicited all-cash tender offer for all of VMA’s outstanding shares of common stock for approximately $3 billion in June 2007. The parties entered into a friendly acquisition agreement for approximately $3.5 billion cash in early 2008, and Roche subsequently completed its acquisition of VMA.

Jay has experience in many industries, including: Real Estate and Real Estate Services, Contract Furnishings, Financial Services, Healthcare, Entertainment Production and Services, Private Trusts, Food Processing and Packaging, Transportation, Professional Service Firms, Wine and Spirits Distribution, Paper Products, Hospitality (hotels, vacation ownership and restaurants), Specialty Distribution, Retail, Venture Capital, Technology, and Mediating Family “Fights”.

STRATEGIC ADVISORY | PRIVATE EQUITY | RESTRUCTURING | TEAM | CASE STUDIES
CONTACT | HOME